insulin_degludec  - Drug Details
📊 Estimates insulin_degludec  Dialyzability By Different_Modalities

insulin_degludec 

Complete Drug Information

Drug Name
insulin_degludec 
Trade Names
Tresiba
Pregnancy Category
AU: B3
Routes of Administration
Subcutaneous
Formula
C274H411N65O81S6
Molar Mass
6104.04
Onset of Action
30–90 minutes
Duration of Action
≤ 42 hours
Volume of Distribution
C274H411N65O81S6

🤰 Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.